心肌梗塞幸存者的十个临床重要亚组:通过隐性类分析识别
Benedikte Irene von Osmanski1, Mikkel Zöllner Ankarfeldt2, Niels Thue Olsen3
1Copenhagen Phase IV Unit, Department of Clinical Pharmacology and Center for Clinical Research and Prevention, Copenhagen University Hospital Bispebjerg and Frederiksberg, Copenhagen, Denmark; Signum Life Science, Copenhagen, Denmark.
International journal of cardiology
|January 8, 2026
概括
潜在类分析确定了10个不同的心肌梗塞 (MI) 幸存者的子组. 这些患者群体的死亡和复发性心脏病发作 (RMI) 的五年风险显著不同,有助于个性化治疗策略.
科学领域:
- 心脏病学 心脏病学
- 生物统计学 生物统计学
- 公共卫生 公共卫生
背景情况:
- 在心肌梗塞 (MI) 患者中存在显著的异质性.
- 对心肌梗塞幸存者的分层化可以改善临床管理和患者的治疗结果.
- 隐性类分析 (LCA) 是识别同质子组的一个有价值的工具.
研究的目的:
- 使用LCA在首次心脏病中幸存者中识别同质子组.
- 通过比较预后来评估已识别的子组的临床相关性.
- 在这些子组中量化五年死亡和复发性心脏病发作 (RMI) 的风险.
主要方法:
- 利用了2016-2018年丹麦全国登记处的数据,用于首次心脏病发作后幸存下来的患者.
- 在LCA模型中包括30个患者特征,根据统计,临床和可重复性标准选择最合适的.
- 使用累积发病率函数和比例危险模型量化五年死亡率和RMI风险.
主要成果:
- 在17018名心肌梗塞幸存者中确定了10个不同的潜伏类.
- 班级表现出不同的模式:一些以ST升高MI为特征,另一些以非ST升高MI为特征,还有几个以共患病或医疗利用为特征.
- 死亡的五年累计发病率从3.2%到60.5%不等,而RMI则从4.4%到13.5%.
结论:
- 隐性类分析成功地确定了10个临床上不同的小组,这些小组是首次心脏病发作幸存者.
- 这些子组在5年死亡率和复发性心脏病发作风险方面显示出明显不同的预后.
- 研究结果支持针对心脏病发作患者的个性化风险分层和管理策略.
更多相关视频
相关概念视频
Comparing the Survival Analysis of Two or More Groups
548
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
548
Heart Failure IV: Classification and Diagnostic Evaluation
313
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
313
Acute Coronary Syndrome III: Diagnostic Studies
207
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
207
Assumptions of Survival Analysis
391
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
391
Cancer Survival Analysis
645
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
645
Cardiomyopathy I: Introduction and Classification
492
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
492


